Napp Pharmaceutical Holdings

Napp Pharmaceuticals is a prominent UK-based pharmaceutical company headquartered on the Cambridge Science Park. As a member of the Mundipharma network of independent associated companies, Napp focuses on delivering innovative medicines across several key therapeutic areas, including pain management, respiratory health, oncology, and inflammatory diseases. The company has a long-standing history in the development of analgesic treatments and has more recently become a leader in the UK biosimilars market through strategic partnerships. Napp provides comprehensive services ranging from medical affairs and regulatory support to marketing and distribution within the United Kingdom. Their portfolio includes well-known brands in respiratory care and high-quality biosimilar versions of complex monoclonal antibodies.